Ingevity Quarterly Income Statements Chart
Quarterly
|
Annual
Ingevity Quarterly Income Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net sales | 365,100,000 | 284,000,000 | 298,800,000 | 376,900,000 | 390,600,000 | 340,100,000 | 371,700,000 | 446,000,000 | 481,800,000 | 392,600,000 | 383,600,000 | 482,000,000 | 419,900,000 | 382,800,000 | 336,000,000 | 376,800,000 | 358,400,000 | 320,300,000 | 325,600,000 | 331,700,000 | 270,600,000 | 288,200,000 | 303,400,000 | 359,900,000 | 352,800,000 | 276,800,000 | 278,600,000 | 311,200,000 | 308,600,000 | 235,200,000 | 229,500,000 | 264,100,000 | 260,300,000 | 218,500,000 | 203,700,000 | 252,000,000 | 248,700,000 | 203,900,000 |
cost of sales | 227,200,000 | 170,600,000 | 196,900,000 | 247,000,000 | 267,400,000 | 240,400,000 | 312,200,000 | 317,000,000 | 328,800,000 | 262,200,000 | 278,200,000 | 305,700,000 | 269,300,000 | 245,000,000 | 231,000,000 | 235,000,000 | 218,600,000 | 194,100,000 | 198,200,000 | 192,100,000 | 186,700,000 | 173,600,000 | 192,400,000 | 220,400,000 | 218,400,000 | 179,700,000 | 181,000,000 | 192,600,000 | 193,100,000 | 150,100,000 | 154,200,000 | 170,900,000 | 170,500,000 | 147,800,000 | 146,400,000 | 171,000,000 | 172,600,000 | 143,900,000 |
gross profit | 137,900,000 | 113,400,000 | 101,900,000 | 129,900,000 | 123,200,000 | 99,700,000 | 59,500,000 | 129,000,000 | 153,000,000 | 130,400,000 | 105,400,000 | 176,300,000 | 150,600,000 | 137,800,000 | 105,000,000 | 141,800,000 | 139,800,000 | 126,200,000 | 127,400,000 | 139,600,000 | 83,900,000 | 114,600,000 | 111,000,000 | 139,500,000 | 134,400,000 | 97,100,000 | 97,600,000 | 118,600,000 | 115,500,000 | 85,100,000 | 75,300,000 | 93,200,000 | 89,800,000 | 70,700,000 | 57,300,000 | 81,000,000 | 76,100,000 | 60,000,000 |
yoy | 11.93% | 13.74% | 71.26% | 0.70% | -19.48% | -23.54% | -43.55% | -26.83% | 1.59% | -5.37% | 0.38% | 24.33% | 7.73% | 9.19% | -17.58% | 1.58% | 66.63% | 10.12% | 14.77% | 0.07% | -37.57% | 18.02% | 13.73% | 17.62% | 16.36% | 14.10% | 29.61% | 27.25% | 28.62% | 20.37% | 31.41% | 15.06% | 18.00% | 17.83% | ||||
qoq | 21.60% | 11.29% | -21.56% | 5.44% | 23.57% | 67.56% | -53.88% | -15.69% | 17.33% | 23.72% | -40.22% | 17.07% | 9.29% | 31.24% | -25.95% | 1.43% | 10.78% | -0.94% | -8.74% | 66.39% | -26.79% | 3.24% | -20.43% | 3.79% | 38.41% | -0.51% | -17.71% | 2.68% | 35.72% | 13.01% | -19.21% | 3.79% | 27.02% | 23.39% | -29.26% | 6.44% | 26.83% | |
gross margin % | ||||||||||||||||||||||||||||||||||||||
selling, general, and administrative expenses | 44,200,000 | 43,100,000 | 39,400,000 | 38,700,000 | 41,400,000 | 47,200,000 | 43,400,000 | 40,000,000 | 51,700,000 | 48,600,000 | 55,900,000 | 54,200,000 | 48,700,000 | 40,000,000 | 48,300,000 | 43,500,000 | 47,500,000 | 40,000,000 | ||||||||||||||||||||
research and technical expenses | 7,800,000 | 7,700,000 | 7,300,000 | 6,700,000 | 7,300,000 | 6,800,000 | 7,200,000 | 7,800,000 | 8,000,000 | 8,800,000 | 7,200,000 | 7,600,000 | 8,200,000 | 7,300,000 | 7,000,000 | 6,800,000 | 5,900,000 | 6,600,000 | 5,800,000 | 5,200,000 | 5,400,000 | 6,200,000 | 4,700,000 | 4,900,000 | 5,000,000 | 5,100,000 | 5,200,000 | 5,600,000 | 5,300,000 | 5,000,000 | 5,200,000 | 4,800,000 | 4,700,000 | 5,100,000 | ||||
restructuring and other (income) charges | 21,900,000 | 12,300,000 | 23,400,000 | 86,900,000 | 13,100,000 | 62,800,000 | 120,800,000 | 24,600,000 | 19,200,000 | 5,600,000 | 3,200,000 | 3,300,000 | 3,700,000 | 3,600,000 | 3,900,000 | 4,100,000 | 4,300,000 | 3,900,000 | 5,200,000 | 5,500,000 | 7,300,000 | 500,000 | -200,000 | 1,700,000 | 300,000 | 100,000 | -600,000 | 200,000 | 100,000 | 1,100,000 | 2,300,000 | 2,900,000 | 32,700,000 | |||||
goodwill impairment charge | 183,800,000 | 349,100,000 | ||||||||||||||||||||||||||||||||||||
acquisition-related costs | -100,000 | -200,000 | 300,000 | -200,000 | 100,000 | 1,800,000 | 1,900,000 | 3,100,000 | 1,900,000 | -300,000 | 200,000 | 400,000 | 300,000 | 100,000 | 400,000 | 1,300,000 | 2,000,000 | 1,300,000 | 800,000 | 22,800,000 | 6,500,000 | 500,000 | 3,800,000 | |||||||||||||||
other income | 4,300,000 | 4,100,000 | 1,900,000 | 111,800,000 | 23,900,000 | 32,200,000 | 19,600,000 | 1,300,000 | 3,000,000 | -18,200,000 | -700,000 | 2,000,000 | -1,600,000 | -1,400,000 | -1,700,000 | 84,600,000 | -4,200,000 | 1,200,000 | -4,000,000 | -3,000,000 | 900,000 | 2,000,000 | -2,000,000 | 1,400,000 | -3,700,000 | -1,700,000 | 2,500,000 | 1,400,000 | -1,200,000 | -400,000 | -500,000 | 1,700,000 | -300,000 | 700,000 | 1,800,000 | -900,000 | 800,000 | |
interest expense | 18,600,000 | 19,400,000 | 28,500,000 | 23,800,000 | 23,200,000 | 22,300,000 | 29,000,000 | 23,100,000 | 21,600,000 | 19,600,000 | 24,500,000 | 11,500,000 | 15,100,000 | 10,700,000 | 15,500,000 | 11,600,000 | 12,200,000 | 12,400,000 | 17,300,000 | 8,900,000 | 10,000,000 | 10,900,000 | 18,300,000 | 12,100,000 | 13,100,000 | 11,100,000 | 11,400,000 | 7,900,000 | 7,800,000 | 6,100,000 | 8,800,000 | 3,200,000 | 2,800,000 | 3,300,000 | 5,100,000 | 3,800,000 | 5,000,000 | 5,400,000 |
income before income taxes | -142,700,000 | 26,800,000 | 8,800,000 | -137,900,000 | -334,600,000 | -71,900,000 | -154,000,000 | 32,100,000 | 47,700,000 | 64,100,000 | 19,700,000 | 95,800,000 | 76,500,000 | 77,600,000 | 36,300,000 | -9,000,000 | 73,700,000 | 61,800,000 | 66,400,000 | 88,100,000 | 25,400,000 | 55,200,000 | 55,100,000 | 77,400,000 | 72,700,000 | 22,700,000 | 43,600,000 | 68,100,000 | 64,600,000 | 45,500,000 | 35,525,000 | 55,100,000 | 53,000,000 | 34,000,000 | 18,300,000 | 10,500,000 | 38,400,000 | 19,800,000 |
benefit for income taxes | 3,800,000 | 6,300,000 | -7,800,000 | -30,700,000 | -50,900,000 | -15,900,000 | -37,200,000 | 6,900,000 | 12,200,000 | 13,400,000 | 4,100,000 | 20,400,000 | 16,700,000 | 16,800,000 | 7,000,000 | -4,800,000 | 29,400,000 | 13,100,000 | 20,400,000 | 18,200,000 | 5,200,000 | 9,900,000 | 10,800,000 | 17,500,000 | 15,900,000 | 1,500,000 | 16,400,000 | 12,400,000 | 9,700,000 | |||||||||
net income | -146,500,000 | 20,500,000 | 16,600,000 | -107,200,000 | -283,700,000 | -56,000,000 | -116,800,000 | 25,200,000 | 35,500,000 | 50,700,000 | 15,600,000 | 75,400,000 | 59,800,000 | 60,800,000 | 29,300,000 | -4,200,000 | 44,300,000 | 48,700,000 | 46,000,000 | 69,900,000 | 20,200,000 | 45,300,000 | 44,300,000 | 59,900,000 | 56,800,000 | 22,700,000 | 42,100,000 | 51,700,000 | 52,200,000 | 35,800,000 | 48,000,000 | 38,400,000 | 35,800,000 | 23,000,000 | 13,600,000 | -4,800,000 | 25,800,000 | 9,800,000 |
yoy | -48.36% | -136.61% | -114.21% | -525.40% | -899.15% | -210.45% | -848.72% | -66.58% | -40.64% | -16.61% | -46.76% | -1895.24% | 34.99% | 24.85% | -36.30% | -106.01% | 119.31% | 7.51% | 3.84% | 16.69% | -64.44% | 99.56% | 5.23% | 15.86% | 8.81% | -36.59% | -12.29% | 34.64% | 45.81% | 55.65% | 252.94% | -900.00% | 38.76% | 134.69% | ||||
qoq | -814.63% | 23.49% | -115.49% | -62.21% | 406.61% | -52.05% | -563.49% | -29.01% | -29.98% | 225.00% | -79.31% | 26.09% | -1.64% | 107.51% | -797.62% | -109.48% | -9.03% | 5.87% | -34.19% | 246.04% | -55.41% | 2.26% | -26.04% | 5.46% | 150.22% | -46.08% | -18.57% | -0.96% | 45.81% | -25.42% | 25.00% | 7.26% | 55.65% | 69.12% | -383.33% | -118.60% | 163.27% | |
net income margin % | ||||||||||||||||||||||||||||||||||||||
per share data | ||||||||||||||||||||||||||||||||||||||
basic earnings per share | -4.02 | 0.56 | 0.46 | -2.95 | -7.81 | -1.54 | -3.2 | 0.7 | 0.98 | 1.36 | 0.44 | 1.99 | 1.55 | 1.56 | 0.75 | -0.11 | 1.11 | 1.21 | 0.818 | 1.69 | 0.49 | 1.09 | ||||||||||||||||
diluted earnings per share | -4.02 | 0.56 | 0.46 | -2.95 | -7.81 | -1.54 | -3.18 | 0.69 | 0.97 | 1.35 | 0.44 | 1.98 | 1.54 | 1.55 | 0.74 | -0.11 | 1.1 | 1.2 | 0.815 | 1.69 | 0.49 | 1.08 | ||||||||||||||||
selling, general and administrative expenses | 26,975,000 | 34,900,000 | 34,500,000 | 38,500,000 | 40,800,000 | 40,700,000 | 42,500,000 | 39,100,000 | 35,900,000 | 34,500,000 | 35,900,000 | 26,500,000 | 27,900,000 | 26,200,000 | 26,300,000 | 26,000,000 | 27,800,000 | 29,700,000 | 28,900,000 | 27,600,000 | ||||||||||||||||||
less: net income attributable to noncontrolling interests | 4,000,000 | 3,200,000 | 2,300,000 | |||||||||||||||||||||||||||||||||||
net income attributable to ingevity stockholders | 44,300,000 | 59,900,000 | 56,800,000 | 22,700,000 | 42,100,000 | 49,500,000 | 46,700,000 | 30,800,000 | 41,600,000 | 33,800,000 | 32,100,000 | 19,000,000 | 10,400,000 | -7,100,000 | ||||||||||||||||||||||||
basic earnings per share attributable to ingevity stockholders | 1.06 | 1.42 | 1.36 | 0.54 | 1 | 1.18 | 1.11 | 0.73 | 0.99 | 0.8 | 0.76 | 0.45 | ||||||||||||||||||||||||||
diluted earnings per share attributable to ingevity stockholders | 1.05 | 1.41 | 1.34 | 0.54 | 0.99 | 1.16 | 1.1 | 0.72 | 0.97 | 0.79 | 0.76 | 0.45 | ||||||||||||||||||||||||||
separation costs | 200,000 | 200,000 | 200,000 | 300,000 | 3,900,000 | 2,500,000 | 4,700,000 | 6,400,000 | ||||||||||||||||||||||||||||||
less: net income attributable to noncontrolling interest | 3,175,000 | 2,200,000 | 5,500,000 | 5,000,000 | 3,075,000 | 4,600,000 | 3,700,000 | |||||||||||||||||||||||||||||||
acquisition costs | 3,000,000 | 4,100,000 | ||||||||||||||||||||||||||||||||||||
benefit from income taxes | 11,225,000 | 16,700,000 | 17,200,000 | 11,000,000 | 4,700,000 | 15,300,000 | 12,600,000 | 10,000,000 | ||||||||||||||||||||||||||||||
basic and diluted earnings per share attributable to ingevity corporation | 0.148 | -0.17 | 0.56 | |||||||||||||||||||||||||||||||||||
less: net income attributable to noncontrolling interests, net of taxes | 2,100,000 | 1,600,000 | ||||||||||||||||||||||||||||||||||||
net income attributable to ingevity corporation | 23,700,000 | 8,200,000 | ||||||||||||||||||||||||||||||||||||
basic and diluted earnings per share | 0.19 |
We provide you with 20 years income statements for Ingevity stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Ingevity stock. Explore the full financial landscape of Ingevity stock with our expertly curated income statements.
The information provided in this report about Ingevity stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.